PubMed=23650391; DOI=10.1073/pnas.1221478110; PMCID=PMC3666732
Mao P., Joshi K., Li J.-F., Kim S.-H., Li P.-P., Santana-Santos L., Luthra S., Chandran U.R., Benos P.V., Smith L., Wang M.-D., Hu B., Cheng S.-Y., Sobol R.W., Nakano I.
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Proc. Natl. Acad. Sci. U.S.A. 110:8644-8649(2013)

PubMed=34934174; DOI=10.1038/s42003-021-02949-7; PMCID=PMC8692581
Li J.-F., Garavaglia S., Ye Z.-F., Moretti A., Belyaeva O.V., Beiser A., Ibrahim M., Wilk A., McClellan S., Klyuyeva A.V., Goggans K.R., Kedishvili N.Y., Salter E.A., Wierzbicki A., Migaud M.E., Mullett S.J., Yates N.A., Camacho C.J., Rizzi M., Sobol R.W.
A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.
Commun. Biol. 4:1420.1-1420.16(2021)